Last reviewed · How we verify

NCT04306133

PENG Block Combined to Wound Infiltration for Hip Replacement

Completed NA Last updated 6 April 2021
What this trial tests

NA trial testing PENG block in Postoperative Pain in 60 participants. Completed in 31 December 2020.

Timeline
9 March 2020
Primary endpoint
24 December 2020
31 December 2020

Quick facts

Lead sponsorCampus Bio-Medico University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment60
Start date9 March 2020
Primary completion24 December 2020
Estimated completion31 December 2020
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Campus Bio-Medico University

Who can join

18 and older, any sex, with Postoperative Pain or Analgesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study analyze the effect of Pericapsular Nerve Group (PENG) Block combined to wound infiltration for analgesia after elective hip replacement. Half of participants will receive a PENG Block combined with wound infiltration, while the other half will receive wound infiltration alone.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Impact of the pericapsular nerve group (PENG) block on postoperative analgesia and functional recovery following total hip arthroplasty: a randomised, observer-masked, controlled trial.
    Pascarella G, Costa F, Del Buono R, Pulitanò R, et al · · 2021 · cited 113× · PMID 34196965 · DOI 10.1111/anae.15536

Verify or expand the search:

Other trials of PENG block

Trials testing the same drug.

Other recruiting trials for Postoperative Pain

Currently open trials in the same condition.

Other Campus Bio-Medico University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04306133.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing